Founded in 2018, atai is a clinical-stage biopharmaceutical company that uses a decentralized business model to accelerate the development of mental health treatments.
"Citi's robust portfolio of products, ongoing technological improvements, global footprint and expertise have allowed atai to implement a best-practice, efficient and scalable cash management operation. Through the professional and well-structured partnership of our coverage team, we have completed our banking structure optimization expeditiously and with minimal administrative stress to the organization."
-Sebastian Giraldo, Director of Treasury, atai Life Sciences N.V.